Stockhub

Can-Fite BioPharma Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 August 2022

27 July 2022

  • curprev 09:3009:30, 27 July 2022‎ Chris talk contribs‎ 1,336 bytes +1,336‎ Created page with "Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinical trial for the treatment of COVID-19. It also develops Namodenoson that is in Phase III clinical trial for the treatment of he..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Can-Fite_BioPharma_Ltd.’